rs1553609185
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001354712.2(THRB):c.1305T>G(p.His435Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H435R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001354712.2 missense
Scores
Clinical Significance
Conservation
Publications
- thyroid hormone resistance, generalized, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- resistance to thyroid hormone due to a mutation in thyroid hormone receptor betaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hormone resistance, generalized, autosomal recessiveInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| THRB | NM_001354712.2 | c.1305T>G | p.His435Gln | missense_variant | Exon 11 of 11 | ENST00000646209.2 | NP_001341641.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| THRB | ENST00000646209.2 | c.1305T>G | p.His435Gln | missense_variant | Exon 11 of 11 | NM_001354712.2 | ENSP00000496686.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Thyroid hormone resistance, generalized, autosomal dominant Pathogenic:2
Variant summary: THRB c.1305T>G (p.His435Gln) results in a non-conservative amino acid change located in the Nuclear hormone receptor, ligand-binding domain (IPR000536) of the encoded protein sequence. Several other missense variants located at this codon have been implicated in association with Thyroid hormone resistance supporting a hotspot codon essential for Thyroid hormone receptor function (Nomura_1996). Specifically, a different variant (c.1305T>A) resulting in the same alteration (p.His435Gln) has been reported in association with Thyroid hormone resistance (Tsakaguchi_1995). Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251472 control chromosomes. Although specifically c.1305T>G has not been reported in the literature, the variant p.His435Gln has been reported in the literature in at-least one individual affected with Thyroid Hormone Resistance, Generalized, Autosomal Dominant and continues to be cited by others (example, Nomura_1996, Anzai_2012, Groenweg_2017, Zaig_2018, Choi_2018). At least one publication reports experimental evidence evaluating an impact of p.His435Gln on protein function (Nomura_1996). The most pronounced variant effect results in T3-binding activity below limit of detection and alters homodimer formation on certain thyroid hormone response elements (TRE) such as DR4. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
Thyroid hormone resistance syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at